default_top_notch
default_news_top
default_news_ad1
default_nd_ad1

Boryung to export anticancer drugs to Philippine

Lee Han-soo  Published 2018.10.12  13:26  Updated 2018.10.12 13:26

공유
default_news_ad2

Boryung Pharmaceutical said Friday that it has signed a deal with Endure Medical, a Philippine-based pharmaceutical company, to export four of its anticancer drugs, during the 2018 CPhI Worldwide Convention in Spain.

Boryung Pharmaceutical Global Sales Department Director Park Jae-rock (third from left) and Endure Medical BD&RA team Head Jonas Angara Depalac hold up their agreement at CPhI Worldwide Convention in Madrid, Spain, Thursday.

The four are EP mycin, AD mycin, Oxalitin and Neoplatin.

Under the agreement, Boryung will supply 5 billion won ($4.4 million) worth of drugs for three years.

The company is already shipping its anticancer drugs to various Southeast Asian countries including Thailand, Indonesia and Vietnam. Based on its export in the region, Boryung plans to expand their business to Africa and South America.

corea022@docdocdoc.co.kr

<© KBR , All rights reserved.>
default_news_ad5
default_news_bottom
default_nd_ad4
default_bottom
#top
default_bottom_notch